STAT3 and pachyonychia congenita: Nuclear STAT3 and STAT5A/B protein levels are increased in high-grade PC, CRPC, and distant metastases, and the high levels of nuclear STAT3 and STAT5A/B expression can predict early disease recurrence and PC-specific death in clinical PC.